期刊文献+

烟酰胺在皮肤科的应用进展 被引量:13

Application Progress of Nicotinamide in Dermatology
下载PDF
导出
摘要 烟酰胺是皮肤科的常用药,主要用作烟酰胺或烟酸缺乏引起的糙皮病等。近年来,一些试验研究及临床用药发现烟酰胺可用于更加广泛的适应证,例如系统用药治疗天疱疮,局部用于治疗痤疮,降低色素沉着以及调节皮肤光免疫反应等。本文综述了烟酰胺在皮肤科的应用新进展。 Nicotinamide is a common medicine of dermatology, which is mainly used in nicotinamide or niacin deficiency caused pellagra. In recent years, a number of laboratory experiments and clinical studies have shown that nicotinamide can be used more widely in dermatology, such as systemic use in pemphigus and topical use in acne, pigmentation reduction and protection against ultraviolet radiation-induced immunosuppression in humans. This article reviews the new application of nicotinamide.
作者 余辉 申国庆
出处 《药学与临床研究》 2014年第3期262-265,共4页 Pharmaceutical and Clinical Research
关键词 烟酰胺 痤疮 色素沉着 光免疫抑制 Nicotinamide Acne Pigmentation Ultraviolet radiation-induced immunosuppression
  • 相关文献

参考文献27

  • 1Effat K, Rohollah FF, M ehdi A, et al. Topical 4% nicotinamide vs. 1% clindamycin in moderate inflam- matory acne vulgaris [J]. Int J Dermatol, 2013, 52(8): 999-1004. 被引量:1
  • 2Shahmoradi Z, Iraji F, Siadat AH, et al. Comparison of topical 5%nicotinamid gel versus 2% clindamycin gel in the treatment of the mild_moderate acne vulgaris: A double_blinded randomized clinical trial [J]. J Res Med Sci, 2013, 18(2): 115-7. 被引量:1
  • 3Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer [J]. Br J Dermatol, 2002, 147(1): 20-31. 被引量:1
  • 4Bissett DL, Miyamoto K, Sun P, et al. Topical niaci- namide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin [J]. Int J Cosmet Sci, 2004, 26(5): 231-8. 被引量:1
  • 5Josefina NS, Juan PC, Bertha T, et al. A double-blind, randomized clinical trial of niacinamide 4% versus hy- droquinone 4% in the treatment of melasma[J]. Derma- tol Res Pract, 2011, 2011: 379173. 被引量:1
  • 6胡国红,万川.烟酰胺凝胶联合2%氢醌乳膏治疗黄褐斑临床疗效观察[J].江西医药,2013,48(11):1065-1066. 被引量:5
  • 7Juan PC, Gabryela L, Adriana E, et al. Topical niaci- namide 4% and desonide 0.05% for treatment of axil- lary hyperpigmentation: a randomized, double-blind, placebo-controlled study [J]. Clin Cosmet lnvestig Der- matol, 2013, 6: 29-36. 被引量:1
  • 8Lee DH, Oh IY, Koo KT, et al. Reduction in facial hyperpigmentation after treatment with a combination of topical niacinamide and tranexamie acid: a randomized, double-blind, vehicle-controlled trial [J]. Skin Res Technol, 2014, 20(2): 208-12. 被引量:1
  • 9Robinson LR, Raleigh PS, Miyamoto K, et al. Reduc- tion in the appearance of facial hyperpigmentation bytopical N-undecyl-10-enoyl-L-phenylalanine and its combination with niacinamide [J]. J Cosmet Dermatol, 2009, 8(4): 260-6. 被引量:1
  • 10Kawada A, Konishi N, Oiso N, et al. Date A. Evalu- ation of anti-wrinkle effects of a novel cosmetic con- taining niacinamide[J]. J Dermatol, 2008, 35(10): 637-42. 被引量:1

二级参考文献15

共引文献14

同被引文献184

引证文献13

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部